WHO ICTRP trial

Dexmedetomidine combined with propofol intravenous sedation in outpatient…

ChiCTR2000033541 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2000033541
Public title Dexmedetomidine combined with propofol intravenous sedation in outpatient imaging in children: a randomized controlled clinical study
Scientific title Dexmedetomidine combined with propofol intravenous sedation in outpatient imaging in children: a randomized controlled clinical study
Primary sponsor Guangzhou Women and Children Medical Center
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 4
Countries China
Conditions Outpatient sedation in children
Interventions Group Chloral hydrate:Oral take 10% chloral hydrate by 0.5ml/kg sedation;Group Propofol:Propofol iv sedation;Group Dex & Pro:Dex&Pro iv sedation
Registration date Jun 4, 2020
Target size Group Chloral hydrate:120;Group Propofol:120;Group Dex & Pro:120
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations